Patients with MDCCAID suffer from congenital muscular dystrophy with hypoglycosylation of dystroglycan (Osborn et al., 2017; Wiessner et al., 2017). This evidence concerns the gene DAG1 and congenital muscular dystrophy due to LMNA mutation.